Evoke Pharma and Spaulding Clinical Research Collaboration for the Exposure Pharmacokinetic Trial
Evoke Pharma, Inc. , a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases announced that the Company has...
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
Allergan, a leading global biopharmaceutical company, announced today that it has entered into a clinical trial agreement with Novartis to...
Medical fair thailand 2017 reflects the bullish growth of the Medical industry in the region
This year’s edition of MEDICAL FAIR THAILAND is set to be its biggest yet with more than 700 international exhibitors...
NuMedii, Inc. Announces New Partnership To Discover New Treatments For Idiopathic Pulmonary Fibrosis
NuMedii, Inc announced the formation of a strategic partnership with Three Lakes Partners, LLC, to discover and advance new treatments for...
Chugai’s phase III ALEX study comparing Alecensa and crizotinib meets primary endpoint
Chugai Pharmaceutical Co., Ltd. announced that Alecensa as an initial (first-line) treatment showed that patients lived significantly longer without disease...
Novartis to strengthen R&D pipeline by in-licensing ECF843 for ophthalmic indications
Novartis announced today that it has exercised an option to in-license ECF843 for ophthalmic indications worldwide (outside Europe). The closing...
Valeo Pharma and Zambon form partnership for Parkinsons Disease Treatment Xadago
Zambon S.p.A., an international pharmaceutical company strongly committed to the central nervous system (CNS) therapeutic area, and Valeo Pharma Inc.,...
Sumitomo announces Partnership with Bukwang on its Atypical Antipsychotic Agent Lurasidone for Korea
Sumitomo Dainippon Pharma Co., Ltd. announced that the Company has concluded a license agreement with Bukwang Pharmaceutical Co., Ltd....
Kyowa Hakko Kirin Announces Positive Results of the Phase 3 Clinical Study of Mogamulizumab (KW-0761)
Kyowa Hakko Kirin Co., Ltd. announced the Global Phase 3 study (MAVORIC: Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) investigating the...
Medidata Wins Informa CARE Award for “Clinical Trial Partnership of the Year”
Medidata the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that its...
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.